Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 5 42-5, 1997, Pages

  Mohammad, Saeed ^a   Zhou, Zhengfeng ^a   Gong, Qiuming ^a   January, Craig T ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Gastrointestinal motility; Potassium channels; Q T interval; Rapidly activating delayed rectifier potassium current; Torsades de pointes

Indexed keywords

CISAPRIDE; GENE PRODUCT; POTASSIUM CHANNEL; POTASSIUM ION;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GASTROESOPHAGEAL REFLUX; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; LONG QT SYNDROME; POTASSIUM CURRENT; PRIORITY JOURNAL; PURKINJE FIBER; STOMACH PARESIS;

EID: 0030693690     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.5.h2534     Document Type: Article

References (28)

1. Ahmed, S. R., and S. M. Wolfe. Cisapride and torsades de pointes. Lancet 345: 508, 1995.
2. Bran, S., W.A. Murray, I. B. Hirsh, and J. P. Palmer. Long QT syndrome during high-dose cisapride. Arch. Intern. Med. 155: 765-768, 1995.
3. Briejer, M. R., L. M. A. Akkermans, and J. A. J. Schuurkes. Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility. Pharmacol. Rev. 47: 631-651, 1995.
4. Craig, D. A., and D. E. Clark. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to 5-hydroxytryptamine 4 receptor. J. Pharmacol. Exp. Ther. 252: 1378-1386, 1990.
5. Curran, M. E., I. Splawski, K. W. Timothy, G. M. Vincent, E. D. Green, and M. T. Heating. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80: 795-803, 1995.
6. Den Hertog, A., and J. Van Den Akker. The effect of cisapride on smooth muscle cells of guinea pig taenia caeci. Eur. J. Pharmacol. 126: 31-35, 1986.
7. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-100, 1981.
8. 4-like receptors in mammalian atria. J. Neural Transm. 34: 195-201, 1991.
9. 4 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 351: 229-236, 1995.
10. McCallum, R. W., C. Prakash, D. Camboli-Richards, and K. L. Goa. Cisapride: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 36: 652-681, 1988.
11. Ohno, N.,M. Itoh, Y. Yokohama, T. Takenichi, and H. Suzuki. Effects of cisapride on electrical and mechanical smooth muscles of the guinea-pig (Abstract). Gastroenterology 104: A560, 1993.
12. Olsson, S., and I. R. Edwards. Tachycardia during cisapride treatment. BMJ 305: 748-749, 1992.
13. Puisieux, F. L., M. M. Adamantidis, B. M. Dumotier, and B. A. Dupuis. Cisapride-induced prolongation of cardiac action potential and early afterdepolarization in rabbit purkinje fibres. Br. J. Pharmacol. 117: 1377-1379, 1996.
14. Roy, M., R. Dumaine, and A. Brown. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94: 817-823, 1996.
15. Kr potassium channel. Cell 81: 299-307, 1995.
16. 4 receptors on the human stomach. J. Gastrointest. Motl. 3: 199, 1991.
17. Snyders, D. J., and A. Chaudhary. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol. Pharmacol. 49: 949-955, 1996.
18. Suessbrich, H., S. Waldegger, F. Lang, and A. E. Busch. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett. 385: 77-80, 1996.
19. 4-like receptor in human colon circular smooth muscle. Br. J. Pharmacol. 115: 172-176, 1995.
20. Taniyama, K., S. Nakayama, K. Takeda, S. Matsuyama, J. Shirakawa, I. Sano, and C. Tanaka. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J. Pharmacol. Exp. Ther. 258: 1098-1104, 1991.
21. Trudeau, M. C., J. W. Warmke, B. Ganetzky, and G. A. Robertson. HERG, a human inward rectifier in the voltagegated potassium channel family. Science 269: 92-95, 1995.
22. Trudeau, M. C., J. W. Warmke, B. Ganetzky, and G. A. Robertson. HERG sequence correction. Science 272: 1087, 1996.
23. Vorperian, V. R., Z. Zhou, S. Mohammad, T. J. Hoon, C. Studenik, and C. T. January. Torsades de pointes with an antihistamine metabolite: potassium channel block with desmethylastemizole. J. Am. Coll. Cardiol. 28: 1556-1561, 1996.
24. Warmke, J. W., and B. Ganetzky. A family of potassium channel genes related to eag in Drosophilia and mammals. Proc. Natl. Acad. Sci. USA 91: 3438-3442, 1994.
25. 25a.Wiseman, L. R., and D. Faulds. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 47: 116-152, 1994.
26. Kr-like K channel, erg. Circ. Res. 80: 261-268, 1997.
27. Wysowski, D. K., and J. Bacsanyi. Cisapride and fatal arrhythmia. N. Engl. J. Med. 335: 290-291, 1996.
28. Zhou, Z., Q. Gong, B. Ye, F. Fan, J. C. Makielski, G. A. Robertson, and C. T. January. Electrophysiological and pharmacological properties of HERG channels in a stably transfected human cell line (Abstract). Biophys. J. 72: A225, 1997.